For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more ...

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

Shares of the biotech Kymera Therapeutics are up 50% since Monday, when data from an early trial hinted that its pill might ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

On June 5, 2025, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) announced the placement of 5,918,000 H shares under its general mandate, representing ...

This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...

Orca Bio is preparing to make a splash in the cell therapy market. | Orca Bio is preparing to make a splash in the cell ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Quarterly Net Profit at Rs. 140.39 crore in March 2025 up 47.75% from Rs. 95.02 crore in March 2024. EBITDA stands at Rs. 199 ...

The U.S. health secretary said people should have access to experimental therapies including unregulated uses of stem cells.